vigabatrin has been researched along with Encephalopathy, Traumatic in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| " We discuss the recent trials of vigabatrin to prevent onset and modify epilepsy outcome in children with tuberous sclerosis (Epistop and PreVeNT)." | 4.02 | Antiepileptogenesis and disease modification: Clinical and regulatory issues. ( Bebin, M; Dichter, MA; Engel, J; French, JA; Hartman, AL; Jóźwiak, S; Klein, P; McNamara, J; Twyman, R; Vespa, P, 2021) |
| " Furthermore, most preclinical antiepileptogenic studies lack information needed for translation, such as dose-blood level relationship, brain target engagement, and dose-response, and many use treatment parameters that cannot be applied clinically, for example, treatment initiation before or at the time of injury and dosing higher than tolerated human equivalent dosing." | 2.66 | Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy? ( Bar-Klein, G; Friedman, A; Hameed, MQ; Jozwiak, S; Kaminski, RM; Klein, P; Klitgaard, H; Koepp, M; Löscher, W; Prince, DA; Rotenberg, A; Twyman, R; Vezzani, A; Wong, M, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klein, P | 2 |
| Friedman, A | 1 |
| Hameed, MQ | 1 |
| Kaminski, RM | 1 |
| Bar-Klein, G | 1 |
| Klitgaard, H | 1 |
| Koepp, M | 1 |
| Jozwiak, S | 2 |
| Prince, DA | 1 |
| Rotenberg, A | 1 |
| Twyman, R | 2 |
| Vezzani, A | 1 |
| Wong, M | 1 |
| Löscher, W | 1 |
| French, JA | 1 |
| Bebin, M | 1 |
| Dichter, MA | 1 |
| Engel, J | 1 |
| Hartman, AL | 1 |
| McNamara, J | 1 |
| Vespa, P | 1 |
1 review available for vigabatrin and Encephalopathy, Traumatic
| Article | Year |
|---|---|
Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy?
Topics: Acetylcysteine; Animals; Anticonvulsants; Antioxidants; Atorvastatin; Brain Injuries, Traumatic; Cef | 2020 |
1 other study available for vigabatrin and Encephalopathy, Traumatic
| Article | Year |
|---|---|
Antiepileptogenesis and disease modification: Clinical and regulatory issues.
Topics: Adult; Anticonvulsants; Brain Injuries, Traumatic; Child; Epilepsy; Humans; National Institute of Ne | 2021 |